SanPower Pharmaceuticals

Originally published on Jan 11 2017, on http://www.caixinglobal.com (Beijing) — Sanpower Group Co. Ltd. has agreed to buy a U.S. maker of cancer vaccines for $820 million, marking the conglomerate’s largest move to date into the global industry for precision medicines. The purchase is one of the largest-ever of an overseas drugmaker by a Chinese […]

via Sanpower to Buy U.S. Cancer-Drug Maker for $820 million — Allison Song